Carvolix raises EUR 10 million from Edwards Lifesciences, Truffle Capital

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation

EW

0.00
  • Carvolix raised a new EUR 10 million tranche in a private financing from Edwards Lifesciences, Truffle Capital at market price.
  • Truffle Capital-backed MedTech group positions itself as a European leader in autonomous mini-robots, AI tools for interventional cardiology.
  • Funding earmarked to accelerate Tavipilot commercialization, support regulatory and clinical milestones, extend liquidity runway beyond 12 months via venture debt.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Truffle Capital SAS published the original content used to generate this news brief on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.